Detrol, Detrol LA, Tolterodine News

Patients treated with Toviaz 8 mg extended release tablets had greater and statistically significant reductions in urge urinary incontinence episodes at week 12 compared with Detrol LA in a placebo-controlled randomized clinical trial.

Nov 16 Nov 6 Oct 26 Recent technological developments in the sequence capture of cellular events through a light microscope can be combined to image multiple independent experiments automatically, with many advantages.

An SPR-based method, Calibration Free Concentration Analysis can be used to accurately determine the concentration of active protein in a sample, relating to the specific binding activity of the protein, and without the need for a standard.

Uroplasty, Inc. , a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results published in the September, 2009 edition of THE JOURNAL OF UROLOGY from the OrBIT trial of its Urgent PC System.

This Article is provided free of charge. Add to File Drawer DRUG NEWS: Fesoterodine for the treatment of overactive bladder On October 31, 2008, the FDA approved fesoterodine fumarate for the treatment of overactive bladder syndrome, which affects about 16% of the adult population, especially the elderly.

MINNEAPOLIS, July 7 MN-Uroplasty-Inc-IUGA MINNEAPOLIS , /PRNewswire-FirstCall/ -- Uroplasty, Inc.

Jun 2, 2009 - Pfizer Inc announced today that Toviaz extended release tablets and the YourWay plan , a comprehensive, customizable support plan for overactive bladder patients, are available in the United States.